A practical guide to choosing a medical device sourcing agent in China. Explore their services, fee models and six selection criteria, with advice on factory audits, private label coordination and quality inspections.

A practical seven-step guide to finding a medical device supplier in China. Learn how to check regulatory documents, verify factory capabilities, evaluate samples and set inspection and payment terms before ordering.

China's medical device exports topped $50 billion in 2025 — but 42% of procurement failures trace back to poor supplier vetting. Learn the 5-phase due diligence protocol for choosing a reliable OEM partner, from certification verification to factory audits and red flags to avoid.

Discover how MedAsia is pioneering at-home healthcare solutions as the industry shifts towards decentralized care. With a robust product portfolio and regulatory expertise, MedAsia partners with businesses for sustainable growth in this evolving market. Are you ready to take advantage of this opportunity?

Discover the critical changes coming with the MDR Reform at Year-End that aim to enhance patient safety and streamline compliance. Key revisions will focus on reducing administrative burdens, improving certification predictability, and fostering international cooperation. Will these changes restore the EU's appeal as a hub for innovative medical devices?

Achieve 80% cost reduction—from $25 to $5 per test—using the Mission® Cholesterol Meter, which delivers lab-accurate results in just 3 minutes. Boost patient follow-up by 60% while unlocking new revenue streams, and empower patients with immediate, accessible health insights. 

By 2025, medical device importers and distributors will face one of the most significant regulatory shifts in decades. The European Union's MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation) deadlines are closing in, while the U.S.

QMSR will align FDA's medical device quality management system with ISO 13485:2016. It will be released by the end of this year and become effective one year later. This harmonization is expected to save medical device companies at least $439 million over the next decade.

With tightening EU regulations like MDR, IVDR, RoHS, and REACH, medical importers and distributors face growing compliance and supply chain risks. This article explores key impacts, actionable steps, and how working with Medasia ensures access to certified, cost-effective, and regulation-ready medical products.

As EU MDR/IVDR and environmental rules tighten, importers face growing compliance demands. This article highlights key 2024–2025 regulatory updates, their impact on importers, and offers practical guidance for compliant sourcing and market access.

The demand for home medical devices in China is surging, driven by an aging population and chronic disease management needs. From blood glucose monitors to AI-driven ventilators, this $42B market is redefining global healthcare accessibility.

Reusable pregnancy tests use a permanent electronic reader with replaceable hCG strips, achieving 99%+ accuracy while eliminating the full plastic device housing discarded after each single-use test. This 2026 guide covers how they work, their environmental and cost advantages, a head-to-head comparison with disposables, and B2B sourcing options.

On 7 November 2024, ECHA added one substance to the SVHC Candidate List, bringing it to 242 entries at that time. Review the applicable communication and reporting duties, and check ECHA’s current list for updates.

Disposable digital pregnancy tests contribute to e-waste, battery contamination, and plastic pollution. This 2026 guide examines their environmental impact, compares sustainable alternatives including reusable digital tests and biodegradable options, and explains why reusable models are the most practical solution for eco-conscious consumers and B2B buyers.

The EU extended transitional deadlines for qualifying legacy in vitro diagnostic devices in 2024. Eligibility depends on device history, manufacturer actions and class-based dates; importers should verify the evidence before relying on an extension.

Discover how AI, wearables, and cutting-edge diagnostics are driving innovation in the medical device industry in 2024, reshaping healthcare delivery while navigating regulatory and cybersecurity challenges.

A look back at the European Commission’s 2024 Q&A guidance on extended IVDR and MDR transition periods, including legacy-device conditions, evidence of eligibility and changes during transition.

Demand for reusable digital ovulation tests is accelerating globally, driven by fertility awareness, sustainability trends, digital health adoption, and expansion into emerging markets. This 2026 market analysis covers the six key demand drivers, a global market outlook, and what distributors and OEM buyers need to know.